Preview

Нефрология

Расширенный поиск

КАРДИОВАСКУЛЯРНЫЕ ЭФФЕКТЫ АЛЬДОСТЕРОНА

https://doi.org/10.24884/1561-6274-2008-12-2-36-38

Полный текст:

Аннотация

В статье содержатся сведения об эффектах альдостерона при связывании с эпителиальными и неэпителиальными минералкортикоидными рецепторами, а также показана патофизиологическая роль данного стероидного гормона в развитии и кардиоваскулярных осложнений при хронической болезни почек. Приведены данные экспериментальных и клинических исследований, доказывающих способность альдостерона вызывать фиброз миокарда и сосудов.

Об авторах

А. Ж. Карабаева
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия

Кафедра нефрологии и диализа факультета последипломного обучения 



А. М. Есаян
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Кафедра нефрологии и диализа факультета последипломного обучения


И. Г. Каюков
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия

Кафедра нефрологии и диализа факультета последипломного обучения

197022,  Санкт-Петербург, тел.:  (812)-34639-26,  факс:  (812)-234-91-91 



Список литературы

1. Christ M, Douwes K, Eisen C et al. Rapid non-genomic effects of aldosterone on sodium transport in rat vascular smooth muscle cells: involvement of the Na+ / H+ antiport. Hypertension 1995; 25: 117-123

2. Camargo MJ, von Lutterotti N, Campbell JrWG et al. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. J Hypertens 1993; 11: 31–40

3. Duprez D, de Buyzere M, Rietzchel ER, Clement DL. Aldosterone and vascular damage. Curr Hypertens Rep 2000; 2; 327-334

4. Epstein M. Aldosterone receptor blockade and the role of eplerenone: evolving perspectives. Nephrol Dial Transpl 2003; 18: 1984-1992

5. Foster RH, MacFarlane CH, Bustamante MO. Recent progress in understanding aldosterone secretion. Gen Pharmacol 1997; 28: 647-651

6. Fuller PJ. Aldosterone’s effects and mechanism of action. Curr Opin Endocrinol Diabetes 1997; 4: 218-224

7. Ebata S, Muto S, Okada K et al. Aldosterone activates Na+ / H+ exchange in vascular smooth muscle cells by non-genomic and genomic mechanisms. Kidney Int 1999; 56: 1400-1412

8. Gekle M, Freudinger R, Mildenberger S, Silbernagl S. Rapid actions of aldosterone on cells from renal epithelium: the possible role of EGF-receptor signaling. Steroids 2002; 67: 499–504

9. Halimi J-M, Mimram A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995; 13: 1801–1802

10. Jalil JE, Janicki JS, Pick R, Weber KT. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: response to captopril. Am J Hypertens 1991; 4: 51–55

11. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 1998; 93: 487-490

12. Laragh JH, Sealy JE. The renin-angiotensin-aldosterone system in hypertensive disorders: a key to two forms of arteriolar constriction and a possible clue to risk of vascular injury (heart attack and stroke) and prognosis. In: Laragh JH, Brenner BM (eds) Hypertension1990; Pathophysiology, Diagnosis, and Management. Raven Press, New York, 1329-1348

13. Nishimura M, Uzu T, Fuji T et al. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999; 33: 261-266

14. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341:709-717

15. Rossi GP, Sachetto A, Visentin P et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996; 27: 1039-1045

16. Rocha R, Martin-Berger CL, Yang P et al. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 2002; 143: 4828-4836

17. Stier Jr CT, Chander PN, Gutstein WH et al. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens 1991; 4: 680-687

18. Stier Jr CT, Adler LA, Levine S, Chander PN. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens 1993; 11 [Suppl 3]: S37-S42

19. Silvestre J-S, Heymes C, Oubenaisso A et al. Activation of cardiac aldosterone production in rat myocardial infarction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999; 99: 2694-2701

20. Schiffrin EL, Franks DJ, Gutkowska J. Effect of aldosterone on vascular angiotensin II reseptors in the rat. Can J Physiol Pharmacol 1985; 63: 1522-1527

21. Takeda R, Matsubara T, Miyamori I et al. Research Committee of Disorders of Adrenal Hormones in Japan. Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. J Endocrinol Invest 1995; 18: 370-373

22. Wehling M. Non-genomic actions of steroid hormones. Trends Endocrinol Metab 1994; 5: 347-353

23. Wehling M, Neylon CB, Fullerton M et al. Non-genomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ Res 1995; 76: 973-979

24. Wehling M, Spes CH, Win N et al. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 1998; 83: 3517-3522

25. Rocha R, Stier CTJ, Kifor I et al. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000; 141: 3871-3878

26. Connell JMC, Davies E. The new biology of aldosterone. Journal of Endocrinology 2005; 186: 1-20


Для цитирования:


Карабаева А.Ж., Есаян А.М., Каюков И.Г. КАРДИОВАСКУЛЯРНЫЕ ЭФФЕКТЫ АЛЬДОСТЕРОНА. Нефрология. 2008;12(2):36-38. https://doi.org/10.24884/1561-6274-2008-12-2-36-38

For citation:


Karabaeva A.Z., Essaian A.M., Kayukov I.G. CARDIOVASCULAR EFFECTS OF ALDOSTERONE. Nephrology (Saint-Petersburg). 2008;12(2):36-38. (In Russ.) https://doi.org/10.24884/1561-6274-2008-12-2-36-38

Просмотров: 87


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)